A New Approach to Rare Disease Clinical Trials
Originally published on Triple Pundit Research studies that test potential treatments for rare diseases have long faced excessive costs, prolonged timelines and a staggering failure rate. One frequently cited 2019 analysis found that over half of randomized controlled trials studying rare diseases — defined as conditions affecting fewer than six patients per 10,000 people — are ultimately […]